OM-85 attenuates high-fat diet-induced obesity, insulin resistance, gut dysbiosis and nonalcoholic steatohepatitis in a murine model

Authors:

Abstract
No abstract available
Funding Information
  • National Institute of General Medical Sciences (1R16GM145586)
  • OM Pharma

This publication has 53 references indexed in Scilit: